Researchers at Massachusetts General Hospital are testing a new drug to reverse Type 1 diabetes.
Jessica Bartlett of the Boston Business Journal joined necn to discuss, saying that funding and finding participants for a clinical trial is the next step in the process.
Read the full BBJ article here.
